|
FBXO3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.82849999994662E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.35889999999195E-05 |
| Normal-vs-Stage2 |
2.361200E-01 |
| Normal-vs-Stage3 |
6.643000E-04 |
| Normal-vs-Stage4 |
3.477300E-03 |
| Stage1-vs-Stage2 |
4.365800E-01 |
| Stage1-vs-Stage3 |
2.131400E-01 |
| Stage1-vs-Stage4 |
2.475600E-01 |
| Stage2-vs-Stage3 |
1.274430E-01 |
| Stage2-vs-Stage4 |
1.250240E-01 |
| Stage3-vs-Stage4 |
7.464800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02670000001748E-06 |
| Normal-vs-AfricanAmerican |
8.475400E-03 |
| Normal-vs-Asian |
1.613840E-01 |
| Caucasian-vs-AfricanAmerican |
4.064400E-01 |
| Caucasian-vs-Asian |
7.051400E-01 |
| AfricanAmerican-vs-Asian |
5.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84079999968156E-07 |
| Normal-vs-Female |
1.614050E-02 |
| Male-vs-Female |
3.777000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.26710000000341E-05 |
| Normal-vs-Extreme_Weight |
4.90080000004056E-06 |
| Normal-vs-Obese |
3.482600E-03 |
| Normal-vs-Extreme_Obese |
3.627600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.244600E-01 |
| Normal_Weight-vs-Obese |
3.181200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.939600E-01 |
| Extreme_Weight-vs-Obese |
4.161200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.479200E-01 |
| Obese-vs-Extreme_Obese |
8.181000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.921140E-03 |
| Normal-vs-Age(41-60Yrs) |
1.481890E-03 |
| Normal-vs-Age(61-80Yrs) |
1.16890000001479E-06 |
| Normal-vs-Age(81-100Yrs) |
7.637500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.269000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.737600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.445400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.570620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.834000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.367800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.402510E-03 |
| Normal-VS-Type2 PRCC |
2.157600E-04 |
| Normal-VS-KIRP CIMP |
2.34069985616259E-10 |
| Normal-VS-Unclassified PRCC |
3.500400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.385190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.175930E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.056600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.321650E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.078200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.580970E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.431300E-04 |
| Normal-vs-N1 |
5.99510000000025E-05 |
| Normal-vs-N2 |
5.62370000012358E-07 |
| N0-vs-N1 |
2.449600E-01 |
| N0-vs-N2 |
9.163700E-02 |
| N1-vs-N2 |
2.059200E-01 |
|
|
